The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced ...

The authorized generic is manufactured by Novo Nordisk, and distributed and sold by Teva. It’s priced at a discount of about ...